STOCKSCREENR

IRWD

NASDAQ

Ironwood Pharmaceuticals, Inc.

$3.25-0.12(-3.56%)Mkt Cap: $529.94M

Key Stats

Market Cap

$529.94M

P/E Ratio

21.67

EPS

$0.15

Dividend Yield

0.00%

52-Week Range

$0.53 — $5.78

Volume

10.41M

Avg Volume

4.57M

Beta

0.19

Valuation

P/E (TTM)

21.67

Forward P/E

3.72

PEG Ratio

-2.25

P/S (TTM)

2.04

P/B (TTM)

-2.29

P/FCF

EV/EBITDA

EV/Sales

Financial Health

ROE (TTM)

-0.08%

ROA (TTM)

0.06%

ROIC

Gross Margin

0.91%

Operating Margin

0.40%

Net Margin

Debt/Equity

-2.28

Current Ratio

1.13

Growth

EPS Growth (YoY)

Revenue Growth (YoY)

EPS Growth (3Y)

-2.12%

EPS Growth (5Y)

+1.07%

Sales Growth (3Y)

-0.05%

Sales Growth (5Y)

-0.03%

EPS Est (This Year)

$0.87

EPS Est (Next Year)

$1.17

Dividends

Dividend Yield

Annual Dividend

Payout Ratio

Frequency

Ex-Dividend Date

Cash/Share

$1.33

Analyst Consensus

Price Target Range

$5.00$5.35$5.70
LowMedianHigh

Consensus Target: $5.35(64.6% upside)

Ownership

Institutional %

Inst. Net Change

Insider Net Shares (90d)

Outstanding Shares

162.68M

Float

156.69M

Free Float %

96.32%

About

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

NASDAQ

IPO Date

2010-02-03

Employees

253

CEO

Thomas A. McCourt

Index Membership

Website

https://www.ironwoodpharma.com

Ironwood Pharmaceuticals, Inc. (IRWD) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $529.94M, a P/E ratio of 21.67, IRWD is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare IRWD against other stocks using dozens of fundamental and technical filters.

Similar Stocks

Frequently Asked Questions

What is Ironwood Pharmaceuticals, Inc.'s P/E ratio?

Ironwood Pharmaceuticals, Inc. (IRWD) has a trailing twelve-month (TTM) P/E ratio of 21.67. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Ironwood Pharmaceuticals, Inc. pay a dividend?

No, Ironwood Pharmaceuticals, Inc. (IRWD) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Ironwood Pharmaceuticals, Inc.'s market cap?

Ironwood Pharmaceuticals, Inc. (IRWD) has a market capitalization of $529.94 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.